CervoMed Inc

Research CervoMed Inc (CRVO) on Bullrun: market cap USD 29.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRVO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 29.16M
• Financial periodFY2025
• RevenueUSD 4.01M
• Revenue growth-58.9%
• Net income-USD 26.97M

Valuation Snapshot

latest market cap is USD 29.16M.

About CervoMed Inc

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression.

Frequently asked questions

What is CervoMed Inc's market cap?

CervoMed Inc's market capitalization is USD 29.16M.

What does CervoMed Inc do?

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.